Back

Invasive and non-invasive quantification of myocardial fibrosis in primary mitral regurgitation: prognostic implications for post-operative remodelling, symptom burden and exercise capacity.

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Still More To Learn on Aortic Stenosis and Mitral Regurgitation Mitral Valve Regurgitation ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Boyang Liu

Wythenshawe Hospital, Manchester (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Effects of bisphosphonate and calcium carbonate on normal aortic valve and cholecalciferol induced in vivo rabbit aortic stenosis model
Associate Professor S. Okutucu (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Lifelong cumulative incidence of acquired aortic stenosis and its predictors in a large middle-aged men population followed up to 42 years
Miss S. Kontogeorgos (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Impact of sex on management and survival in aortic stenosis
Doctor Y. Bohbot (Amiens, FR)
Abstract Slides Video
Presentation thumbnail
Determinants and prognostic significance of focal myocardial fibrosis by cardiac magnetic resonance imaging in patients with mitral valve prolapse
Doctor A. Bouttier (Nantes, FR)
Abstract Slides Video
Presentation thumbnail
Predictors of sudden cardiac arrest in adolescents with mitral valve prolapse: an analysis of the nationwide inpatient sample
Doctor B. Narasimhan (Houston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Still More To Learn on Aortic Stenosis and Mitral Regurgitation

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources